The Deal
Sunday, November 8, 
12:16 am

Andreessen on Facebook, Twitter, MySpace strategy

Posted on July 6, 2009 at 4:45 PM
Filed under: Corporate Strategy | Growth Strategy
Tagged: , , ,
[ Share ]  [ E-mail ]  [ Leave a Comment ]
Marc Andreessen, the serial entrepreneur whose new VC fund was featured on our sister blog Dealscape, said a few words on the corporate strategy of social networking sites Facebook Inc. and MySpace and microblogging site Twitter.

Andreessen (pictured), who founded Netscape Communications Corp., is on Facebook's board and has invested in Twitter. Facebook passed MySpace in terms of U.S. visitors for the first time in May, according to comScore Inc., and Andreessen admitted to Reuters that he regretted not investing in it. He also said it could do more to monetize its 250 million users and could start earning billions five years from now.

On Twitter, he told Reuters it's OK Twitter isn't making money for now because the site needs to focus on increasing its number of users and improving the features it offers so that no rival can swoop in. He also noted a hiccup in the strategy at MySpace, saying it focused too much on selling advertisements and not enough on developing the platform, leaving room for Facebook to come in and take market share. Even so, MySpace, which is cutting about 30% of its U.S. staff, still generates hundreds of millions of dollars more in revenue than Facebook.

Andreessen founded his VC fund -- Andreessen Horowitz -- along with partner Ben Horowitz. They say the new $300 million fund will have the ability to invest between $50,000 and $50 million in a company, depending on the stage and the opportunity. He said in a blog post, "Many of the best new technology companies require far less money up front to build the first product, but far more money later to scale into today's enormous global market, as compared to historical norms." - Baz Hiralal

Go to the story



Join Corporate Dealmaker's LinkedIn forum

Comments
Post a comment


Search


Search For

Corporate Dealmaker Video


Linklaters' Schmidt on Pfizer-Wyeth review

Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.
Decade of The Deal


Movers & Shakers


Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.

Eric Hausler
Isle of Capri Casinos Inc.
Juergen Lasowski, Onyx Pharmaceuticals Inc.
Edward Swallow, Northrop Grumman Corp.
Owen Mahoney, Outspark
Alice Kim, FLO TV Inc.
Eric Hausler, Isle of Capri Casinos Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives


Syndicate

Contributors

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.